Clorox Company (CLX) 13F Holders & Ownership Data (1054 Funds, Q2 2026)

CLX ranks #441 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

CLX is a top-conviction position for Nuance Investments, LLC — at 8.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CLX belongs to BlackRock, Inc., but the position matters far more to Nuance Investments, LLC, who has 8.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Israel Englander has added to its CLX position for two straight quarters, increasing it by $143.1M to reach $222.8M today.

Arrowstreet Capital, Limited Partnership has trimmed its CLX position for two straight quarters, cutting it by $158.5M while still holding $4.8M.

CLX is down 0.7% today, but institutions show net buying of $2.1B this quarter — a divergence between today's price move and the underlying institutional flow.

CLX posted net income of $756.0M over the trailing twelve months, and currently trades at a P/E of 15.2.

• Profitable — net income of $756.0M over the trailing twelve months
• Revenue declined 3.7% year over year
• Net income improved year over year, from $694.0M to $756.0M
• Generated $612.0M in positive operating cash flow
• Current ratio of 0.66x — below the conventional 1.5x liquidity buffer
• Liabilities run 83.80x equity — a highly leveraged balance sheet worth noting